We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sandoz Says To High Court: No Violation Of Biologics Price Competition And Innovation Act

(June 3, 2016, 7:55 AM EDT) -- WASHINGTON, D.C. — Sandoz Inc. argues in a May 17 brief to the U.S. Supreme Court that an appellate court properly concluded both that Sandoz did not violate the Biologics Price...
To view the full article, register now.